Final decision lies with FDA commissioner, but unanimous vote to withdraw widely-used cancer drug is significant
Read more:
FDA panel: Nix Avastin’s use for breast cancer
If you enjoyed this post, make sure you subscribe to my RSS feed!
Final decision lies with FDA commissioner, but unanimous vote to withdraw widely-used cancer drug is significant
Read more:
FDA panel: Nix Avastin’s use for breast cancer
Tagged with: decision-lies fda news